IO Biotech, Inc.·4

Dec 23, 6:56 PM ET

Zocca Mai-Britt 4

4 · IO Biotech, Inc. · Filed Dec 23, 2024

Insider Transaction Report

Form 4
Period: 2024-12-23
Zocca Mai-Britt
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2024-12-23$0.81/sh+12,500$10,12049,891 total
Holdings
  • Common Stock

    (indirect: Zocca Consulting ApS)
    26,580
Footnotes (2)
  • [F1]The actual purchase price is $0.809556 per share of Common Stock, which has been rounded due to systematic character limitations.
  • [F2]The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of her pecuniary interest therein.

Documents

1 file
  • 4
    form4.xmlPrimary